By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Marinus Pharmaceuticals 

21 Business Park Drive

Branford  Connecticut  06405  U.S.A.
Phone: 203-315-0566 Fax: 203-315-0565



Start Up

Company News
Marinus Pharmaceuticals Bolsters Its Board Of Directors And Executive Management 1/9/2014 9:45:34 AM
RusnanoMedInvest and Domain Associates Invest $21 Million in Neurology Company Marinus Pharmaceuticals 1/7/2013 10:28:28 AM
Marinus Pharmaceuticals Experimental Epilepsy Treatment Shows Promise in Open-Label Extension Study 12/21/2011 7:39:41 AM
Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder 4/21/2011 6:59:08 AM
Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome 4/13/2011 11:20:54 AM
Marinus Pharmaceuticals Issued Patent for Ganaxolone 4/7/2011 6:59:18 AM
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors 7/29/2009 8:51:39 AM
Marinus Pharmaceuticals Raises $20 Million in Series B Financing 4/10/2009 6:57:23 AM
Marinus Pharmaceuticals Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures 3/3/2009 8:22:10 AM
Marinus Pharmaceuticals Completes Two Phase 2 Milestones for Ganaxolone in Epilepsy Marinus Closes Phase 2 Trials for Infantile Spasms and Completes Enrollment for Phase 2 Trial in Adult Partial Complex Seizures 10/7/2008 9:43:09 AM